Bausch Health
BHC
#3989
Rank
โ‚น296.30 B
Marketcap
โ‚น791.69
Share price
0.59%
Change (1 day)
45.63%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): -โ‚น207.27

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -โ‚น212.18. In 2025 the company made an earnings per share (EPS) of โ‚น39.26 an increase over its 2024 EPS that were of -โ‚น11.22.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น207.27-627.98%
2025โ‚น39.26-450%
2024-โ‚น11.22-92.59%
2023-โ‚น151.42160.89%
2022-โ‚น58.04-76.64%
2021-โ‚น248.4468.45%
2020-โ‚น147.49-68.91%
2019-โ‚น474.35-57.11%
2018-โ‚น1,106-272.22%
2017โ‚น642.25-199.29%
2016-โ‚น646.81798.7%
2015-โ‚น71.97-128.31%
2014โ‚น254.24-204.62%
2013-โ‚น243.02602.7%
2012-โ‚น34.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น17.76-91.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น88.80-58.15%๐Ÿ‡บ๐Ÿ‡ธ USA